Yigal Nochomovitz
Stock Analyst at Citigroup
(2.37)
# 2,344
Out of 4,818 analysts
294
Total ratings
37.34%
Success rate
-1.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $33.23 | +5.33% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $26.95 | +74.40% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $12.46 | +52.49% | 16 | Mar 7, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $28 → $19 | $9.07 | +109.48% | 9 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.19 | +202.36% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $13.01 | +222.83% | 8 | Mar 4, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $206 → $215 | $166.37 | +29.23% | 4 | Feb 20, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $4.76 | +425.21% | 1 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $89 → $82 | $38.60 | +112.44% | 21 | Feb 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $33 | $6.75 | +389.25% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $41.90 | +131.50% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.37 | +2,080.43% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $0.84 | +610.31% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $51 | $17.49 | +191.60% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.86 | +105.97% | 14 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $9.96 | +171.08% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.85 | +135.29% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $21.08 | +70.78% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $18.84 | +207.94% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $2.06 | +967.96% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.71 | +718.71% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.32 | +270.94% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $8.14 | +367.12% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $5.19 | +169.75% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.46 | +37.46% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $33.60 | +96.43% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $12.70 | +277.95% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.08 | +293.70% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $2.44 | +228.54% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.73 | -63.30% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $6.93 | +405.05% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $37.38 | +255.81% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.67 | +1,090.83% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.97 | +518.49% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.44 | +1,011.11% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.35 | +640.74% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.91 | +1,658.05% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.97 | +509.14% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.03 | - | 14 | Sep 28, 2021 |
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $33.23
Upside: +5.33%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $26.95
Upside: +74.40%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $12.46
Upside: +52.49%
Arvinas
Mar 7, 2025
Maintains: Neutral
Price Target: $28 → $19
Current: $9.07
Upside: +109.48%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.19
Upside: +202.36%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $13.01
Upside: +222.83%
Krystal Biotech
Feb 20, 2025
Maintains: Neutral
Price Target: $206 → $215
Current: $166.37
Upside: +29.23%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $4.76
Upside: +425.21%
CRISPR Therapeutics AG
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $38.60
Upside: +112.44%
EyePoint Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $6.75
Upside: +389.25%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $41.90
Upside: +131.50%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.37
Upside: +2,080.43%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $0.84
Upside: +610.31%
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $17.49
Upside: +191.60%
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $4.86
Upside: +105.97%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $9.96
Upside: +171.08%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.85
Upside: +135.29%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $21.08
Upside: +70.78%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $18.84
Upside: +207.94%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $2.06
Upside: +967.96%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.71
Upside: +718.71%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.32
Upside: +270.94%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $8.14
Upside: +367.12%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $5.19
Upside: +169.75%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.46
Upside: +37.46%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $33.60
Upside: +96.43%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $12.70
Upside: +277.95%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $5.08
Upside: +293.70%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $2.44
Upside: +228.54%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.73
Upside: -63.30%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $6.93
Upside: +405.05%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $37.38
Upside: +255.81%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.67
Upside: +1,090.83%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.97
Upside: +518.49%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.44
Upside: +1,011.11%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.35
Upside: +640.74%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.91
Upside: +1,658.05%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.97
Upside: +509.14%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.03
Upside: -